For the quarter ending 2025-09-30, BMEA had -$9,582K decrease in cash & cash equivalents over the period. -$11,550K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -16,407 | -50,002 |
| Depreciation expense | 427 | 935 |
| Non-cash operating lease expense | 117 | 1,557 |
| Stock-based compensation expense | 1,940 | 5,742 |
| Change in fair value of warrant liability | -3,872 | -227 |
| Impairment of property and equipment | 2,205 | - |
| Prepaid expenses and other current assets | -5,641 | -1,614 |
| Other assets | -4 | -615 |
| Accounts payable | -1,828 | -4,703 |
| Accrued expenses and other current liabilities | 400 | 1,308 |
| Operating lease liabilities | -177 | -1,718 |
| Net cash used in operating activities | -11,550 | -44,879 |
| Purchase of property and equipment | 0 | 0 |
| Net cash used in investing activities | 0 | 0 |
| Proceeds from issuances of common stock under at the market equity offering program | 0 | 5,032 |
| Proceeds from issuance of common stock, common warrants and pre-funded warrants from public offerings | 2,596 | 37,800 |
| Payments of financing costs | 628 | 125 |
| Proceeds from stock option exercise and purchases under the employee stock purchase plan | 0 | 117 |
| Net cash provided by financing activities | 1,968 | 42,824 |
| Net decrease in cash, cash equivalents, and restricted cash | -9,582 | -2,055 |
| Cash and cash equivalents at beginning of period | 58,648 | - |
| Cash and cash equivalents at end of period | 47,011 | - |
Biomea Fusion, Inc. (BMEA)
Biomea Fusion, Inc. (BMEA)